We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 33

Australian antitrust enforcement focuses on healthcare & life sciences

  • Jones Day
  • -
  • Australia
  • -
  • December 22 2014

The Australian Competition and Consumer Commission (ACCC) has continued its focus on the healthcare and life sciences sectors this year, most

Hospital’s by-laws flatline on the competition table

  • King & Wood Mallesons
  • -
  • Australia
  • -
  • December 22 2014

The ACCC has launched proceedings in the Federal Court against Little Company of Mary Health Ltd and its subsidiary Calvary Health Care Riverina Ltd

Federal government’s “action plan” for Australia will the direct selling sector be affected?

  • Addisons
  • -
  • Australia
  • -
  • December 2 2014

In November 2014 the Australia federal government released its Industry Innovation and Competitiveness Agenda (the Agenda), a report1 outlining the

ACCC imposes strict transparency provisions on updated Medicines Australia Code of Conduct

  • King & Wood Mallesons
  • -
  • Australia
  • -
  • October 28 2014

Roll-out of a new edition of Medicines Australia’s Code of Conduct has struck a roadblock, with the ACCC requesting that Medicines Australia amend

ACCC pursues Pfizer over Lipitor drug

  • HopgoodGanim
  • -
  • Australia
  • -
  • September 2 2014

Click here to view the video

Below cost pricing?

  • King & Wood Mallesons
  • -
  • Australia
  • -
  • September 1 2014

According to reports in Friday's Australian FianancialRreview, (Hannah Low, page 32), the ACCC has sought to widen its claim against Pfizer. We

ACCC allegedly misled by Medicines Australia Code of Conduct

  • Russell Kennedy
  • -
  • Australia
  • -
  • August 25 2014

We previously reported that Medicines Australia submitted its 18th Edition of the Code of Conduct for approval by the ACCC. Subsequently, the Royal

By the numbers

  • King & Wood Mallesons
  • -
  • Australia
  • -
  • August 13 2014

The CMA has seen a decline in the overall number of merger decisions in the past year. It made 65 phase 1 merger decisions in 2013-14, down from 100

A summary of major developments in key areas - general counsel update - July 2014

  • Herbert Smith Freehills LLP
  • -
  • Australia, European Union, Hong Kong, United Kingdom
  • -
  • July 15 2014

Legislation, in the form of a Regulation and Directive, has been published in the Official Journal of the European Union which will substantially

ACCC opposes Healthscope's proposed acquisition of Brunswick Private Hospital

  • Corrs Chambers Westgarth
  • -
  • Australia
  • -
  • June 30 2014

On 12 June 2014, the ACCC announced that it will oppose the proposed acquisition of Brunswick Private Hospital by Healthscope Limited (Healthscope